Status:
COMPLETED
IMRT Lower Limb Soft Tissue Sarcoma
Lead Sponsor:
University Health Network, Toronto
Collaborating Sponsors:
Ontario Cancer Research Network
Conditions:
Sarcoma
Eligibility:
All Genders
16+ years
Phase:
PHASE2
Brief Summary
Intensity-modulated radiation therapy may make wound healing problems less likely by 1)precisely shaping the region of high radiation dose to the shape of the tissue which harbours tumour cells, and 2...
Eligibility Criteria
Inclusion
- Histologically proven soft tissue sarcoma
- Lesion lies between the iliac crest (hipbone) and the ankle
- Lesion is newly diagnosed
- Assessed by radiation oncologist and surgical oncologist
Exclusion
- Benign histologies
- Histologies generally treated with chemotherapy
- Prior or recurrent cancer, except nonmelanomatous skin cancer or carcinoma in-situ of the cervix
Key Trial Info
Start Date :
May 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2013
Estimated Enrollment :
59 Patients enrolled
Trial Details
Trial ID
NCT00188175
Start Date
May 1 2003
End Date
May 1 2013
Last Update
June 3 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Princess Margaret Hospital
Toronto, Ontario, Canada, M5G 2M9